The stock trades at just 18x forward EPS, which is an 18% discount to the S & P 500 compared to an historical average of about a 24% premium. At about 17.3x forward EPS, we believe that patient investors could be well rewarded over time as investment spending continues. Looking ahead, these efforts should allow BDX to consistently achieve its long-term growth algorithm of mid-single-digit organic revenue growth and low-double-digit EPS growth. BDX shares currently trade at 15.4x forward EPS – a significant discount to both the S & P 500 and its Medtech peers. Shares trade at 27.5x forward EPS and a 16% discount to Mastercard, which seems unwarranted.

---

Persons: Farr, Miller, Donaldson, DCI YTD, Danaher, Becton Dickinson, Becton, BDX, shortsightedness Organizations: DCI, Donaldson, Management, Valmont Industries, VMI, Valmont, DBS, Web Services, Artificial Intelligence, AMZN, Dickinson, Microsoft, Visa, Mastercard, Google, Android, Accenture, Information Technology, Consulting, Services, The Locations: Washington, American